TWP-201

重组人促卵泡激素Fc融合蛋白（泰泽惠康）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTWP-201
Drug Alias NameTWP-201
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, FemaleAnovulationInfertility
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTherawisdom Biopharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesTherawisdom Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInfertility, FemaleAnovulation
Inactive IndicationsInfertility

Other Information

ATC CodeN/A
Related LinksN/A